X Prize Foundation Is Betting on Placenta Stem Cells to Improve, Extend Life

Feb.15 -- Peter Diamandis, chairman at X Prize Foundation, discusses how scientists have been working within Celgene to use placental cells for regenerative medicine, to fight cancer and treat patients with autoimmune diseases. He speaks with Bloomberg’s David Westin and Alix Steel on "Bloomberg Daybreak: Americas."



(Source: Bloomberg Technology, https://www.youtube.com/watch?v=8jadFG4f3Y0)